Semnur Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.3M
Liabilities Breakdown FY2025
Total Liabilities: $22.1M
Asset Breakdown
Total Assets: $1.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.0K | 1.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $750.0K | 55.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $576.0K | 42.8% |
Liabilities Breakdown
Total Liabilities: $22.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.9M | 26.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.2M | 73.2% |